Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.
about
MicroRNA-29a plays a suppressive role in non-small cell lung cancer cells via targeting LASP1MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1.Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1)An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker proteinPrognostic significance of low microRNA-218 expression in patients with different types of cancer: Evidence from published studies.The impact of pri-miR-218 rs11134527 on the risk and prognosis of patients with esophageal squamous cell carcinoma.MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1.MiR-218 inhibits HMGB1-mediated autophagy in endometrial carcinoma cells during chemotherapy.Differentially Expressed MicroRNAs in Meningiomas Grades I and II Suggest Shared Biomarkers with Malignant Tumors.RETRACTED: Up-regulation of miR-130b expression level and down-regulation of miR-218 serve as potential biomarker in the early detection of human osteosarcomaTumor-suppressing roles of miR-214 and miR-218 in breast cancer.MicroRNA-218 modulates activities of glioma cells by targeting HMGB1.Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancerXIAP 3'-untranslated region as a ceRNA promotes FSCN1 function in inducing the progression of breast cancer by binding endogenous miR-29a-5p.Functional significance of aberrantly expressed microRNAs in prostate cancer.miRNA-186 inhibits prostate cancer cell proliferation and tumor growth by targeting YY1 and CDK6.Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer.Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer.Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals.Proteomic-based investigations on the mode of action of the marine anticancer compound rhizochalinin.Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma.MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.Tumour-suppressive microRNA-29s directly regulate LOXL2 expression and inhibit cancer cell migration and invasion in renal cell carcinoma.MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer.Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.microRNA-32 induces radioresistance by targeting DAB2IP and regulating autophagy in prostate cancer cells.miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer.Regulation of actin-binding protein ANLN by antitumor miR-217 inhibits cancer cell aggressiveness in pancreatic ductal adenocarcinoma.Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer.MicroRNA-206 inhibits the viability and migration of medulloblastoma cells by targeting LIM and SH3 protein 1.Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma.Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell aggressiveness and is involved in prostate cancer pathogenesis.Impact of novel oncogenic pathways regulated by anti-tumor miR-451a in renal cell carcinoma.MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1.Regulation of NCAPG by miR-99a-3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC.Long noncoding RNA MALAT1 knockdown reverses chemoresistance to temozolomide via promoting microRNA-101 in glioblastoma.MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1.MiR-218 regulates epithelial-mesenchymal transition and angiogenesis in colorectal cancer via targeting CTGF.
P2860
Q30008813-D778E472-736A-405A-AEFA-DB3563C74B27Q30008853-C16263C8-B3EB-4F8E-8E7A-0C34C3FB968CQ30008871-2FA36E2F-8CED-45E2-8B8C-8EA9952FC8ECQ30009240-00E29C4D-E9B8-4210-AF2A-4F541B94CE82Q30245349-60B402B7-49DF-4A1F-9010-D73EEDE2F944Q34371709-72598CBD-8C44-48F4-B5B1-6B300FF7439BQ35678702-B8C86613-4FBD-4896-A0AF-29745D51DA90Q35827610-6A05A2F6-641A-48A1-BEFA-EA7BF484DD6FQ35919064-FDE7642A-4912-4B07-8847-483E94FF2097Q35947699-B91F43F2-F50E-4CE0-84C1-A60273B8018EQ36131618-0DAE70CE-9B30-44B7-A8F1-C1D2D0537998Q36908874-D86FA2A2-DD6F-4179-B3B2-12A97C27D91CQ37293145-68EE4985-28AB-4C21-B97B-4901DB0AED1BQ37702680-652D0C7C-0D40-4F39-B124-22515FEE4938Q37725519-D2C21285-F26F-4069-B121-45BF60AB7494Q38323461-12B35FE3-4D93-4003-87EE-1D9A6CF6DFE0Q38701099-22F294A8-988D-4170-A53D-C802E66349DDQ38765720-587F0341-18A7-4F02-86E0-6F39C17D93C2Q38769219-55C52708-07D2-430E-96C2-C2EA7166A81FQ38816103-CCD0FB49-7910-451B-937F-BDA716CFE1E8Q38818816-9C683580-6037-414D-B228-782AF72541B4Q38824206-0D23F7C5-B1A3-4E69-BB2D-687957872792Q38826075-EBD665BA-FFA7-4C8A-8996-56878D5650B6Q38839158-7C7F75DF-102B-47D8-AD9A-0B34DC26D9A4Q38861461-36FEF80F-D356-466B-BA17-6903D5D6624DQ38865588-C09BE8E0-E26F-4303-A342-AAC38A3BB266Q39384713-0DA0508F-3DE3-4A36-AE70-2405A85A3830Q40257658-60D367E3-A58A-4D22-999A-1C7CEDCD2754Q41082524-DC3D44B4-59C3-4C25-8F74-8C9EA81932E0Q41593099-709606CC-095E-47B8-B742-F3943B5D5D0AQ41684266-42C2C5C4-3FD5-4154-BA92-6E90AD3A8713Q42376442-21DBB76D-EE04-4397-8002-188417E2EAE4Q47426573-47EAB72A-B387-4420-B3F2-A4B8290E2D36Q48193099-09CDEFBD-C5A1-45E7-9B61-E92A4F7E395AQ50124873-89202589-DA46-45E2-85F4-41C414A71E2BQ51075372-D8436EEB-AF27-4E38-B265-069FD6639083Q52334742-25DABE72-EF9E-40F8-8BCE-628580156513Q52685797-BE5B1E90-1E96-47AC-B5A3-C8EEAED28332Q53508904-CF342D5C-C96C-47AC-B420-062C1838FCD3Q55453435-FF1CFA15-7C14-478F-85F8-87E397D374D0
P2860
Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tumor-suppressive microRNA-218 ...... g of LASP1 in prostate cancer.
@ast
Tumor-suppressive microRNA-218 ...... g of LASP1 in prostate cancer.
@en
type
label
Tumor-suppressive microRNA-218 ...... g of LASP1 in prostate cancer.
@ast
Tumor-suppressive microRNA-218 ...... g of LASP1 in prostate cancer.
@en
prefLabel
Tumor-suppressive microRNA-218 ...... g of LASP1 in prostate cancer.
@ast
Tumor-suppressive microRNA-218 ...... g of LASP1 in prostate cancer.
@en
P2093
P2860
P3181
P356
P1433
P1476
Tumor-suppressive microRNA-218 ...... g of LASP1 in prostate cancer.
@en
P2093
Hideki Enokida
Masayuki Nakagawa
Naohiko Seki
Noriko Yamamoto
Rika Nishikawa
Satoko Kojima
Shinichi Sakamoto
Takashi Kinoshita
Takeshi Chiyomaru
Tomohiko Ichikawa
P2860
P304
P3181
P356
10.1111/CAS.12441
P577
2014-06-18T00:00:00Z